Learn More
PURPOSE This was an open, randomized, multicenter, phase I/II study to investigate the safety and tolerability of cetuximab in the first-line treatment of recurrent/metastatic squamous cell carcinoma(More)
5511 Background: Head and neck cancer (HNC) patients will often experience local failure. Surgery is an accepted means of treating patients who have received prior full-dose radiotherapy (RT)(More)
  • 1